AUS
NZ
UK
CA
USA
IND
Healthcare
Cochlear (ASX:COH) Announces Key Changes to Executive Team
July 26, 2024 03:50 PM AEST| By Team Kalkine MediaCochlear Limited (ASX:COH), a global leader in implantable hearing solutions, has announced significant changes to its executive team as part of its strategic leadership transition. These changes reflect the company’s commitment to maintaining its gr...
Polynovo (ASX:PNV) Reports Stellar FY24 Sales of AU$92 Million, Shares Rise 57.1% Year-to-Date
July 24, 2024 04:33 PM AEST| By Team Kalkine MediaShares of Polynovo (ASX:PNV) surged by as much as 6.2% to AU$2.760, marking their highest level since July 2, 2021, as the stock continued its upward momentum from the previous session. Analysts at Macquarie have projected significant sales growth of...
Two ASX Healthcare Stocks Facing Declines Amid Market Challenges
July 24, 2024 02:08 PM AEST| By Team Kalkine MediaOn a challenging Wednesday for the S&P/ASX 200 Index, which sees marginal losses hovering around 7,967.4 points, several stocks stand out for their notable declines. Here’s a closer look at why these healthcare companies are struggling today:,Mesobla...
CSL Ltd and Washington H. Soul Pattinson & Company Ltd Share Prices Worth Watching
July 24, 2024 12:00 AM AEST| By Team Kalkine MediaCSL Ltd,(ASX: CSL),, a leading global biotechnology company, has seen its share price increase by 8.3% since the start of 2024. CSL is known for its innovative medicines that address serious medical conditions and contribute to public health. The com...
Ansell (ASX: ANN) Rises on Strategic Acquisition of Kimberly-Clark's PPE Business
July 23, 2024 04:57 PM AEST| By Team Kalkine MediaAnsell Ltd (,ASX: ANN,), a prominent supplier of medical equipment, saw its shares surge by 3.5% to AU$ 27.570, marking its highest level since July 17, 2023. The rally follows upbeat commentary from analysts at J.P. Morgan regarding Ansell's recent...
_08_02_2023_11_21_17_866226.jpg)
Polynovo’s (ASX: PNV) Share Price Surges 5% on FY24 Results
July 23, 2024 03:22 PM AEST| By Team Kalkine MediaPolynovo Ltd (,ASX: PNV,) has seen its share price climb 5% into the green on Tuesday following the release of its unaudited FY24 trading results. These results indicate robust performance across the board for the medical device company, driving inve...
_05_28_2024_07_35_45_631343.jpg)
Pro Medicus (ASX: PME): Insider Ownership and Institutional Influence
July 22, 2024 10:31 AM AEST| By Team Kalkine MediaPro Medicus Limited (,ASX: PME,),, a prominent player in the healthcare technology sector, showcases a distinct ownership structure that reflects the inherent interests of its key stakeholders in the company’s growth and expansion. Understanding the...
ASX Health Stock: Immutep's Trial Approval, Alcidion's $4M Contract
July 17, 2024 11:40 AM AEST| By Team Kalkine MediaHeadline,Alcidion Signs $4M Contract for Patient Care Platform with HRHA,Immutep and Alcidion Make Strides with Key Approvals and Contracts,Immutep Receives Approval for Phase 1 Trial of Autoimmune Therapy,Immutep (,ASX: IMM,), a biotech company spec...
Mesoblast (ASX: MSB) Faces Share Price Downturn Despite FDA Milestone for Ryoncil
July 09, 2024 01:01 PM AEST| By Team Kalkine MediaDespite a buoyant market, Mesoblast Ltd (,ASX: MSB,), a leading biotechnology firm specialising in allogeneic cellular medicines, is witnessing a downturn in its share price today. As of Tuesday morning trade, the company's shares have dipped by 4.5%...
Ansell (ASX: ANN) Finalises Major Acquisition, Eyes Growth Despite Steady Share Price
July 02, 2024 02:36 PM AEST| By Team Kalkine MediaAnsell Ltd (,ASX: ANN,) has finalised a significant acquisition, acquiring all assets of Kimberly-Clark Corporation's (NYSE: KMB) personal protective equipment (PPE) business. This transaction, initially announced on 8 April 2024, amounts to AU$970 m...
Sonic Healthcare (ASX: SHL) Faces Analyst Caution Amid Challenging Outlook
July 01, 2024 01:58 PM AEST| By Team Kalkine MediaMacquarie's latest forecasts for Sonic Healthcare (,ASX: SHL,) suggest a cautious stance on the company's future earnings, projecting FY25 EBITDA of AU$1.69 billion, which stands 8% below Visible Alpha consensus estimates.,Analyst Rating and Market R...
Healius (ASX: HLS) Shares Tumble on Downgraded FY24 Guidance
June 25, 2024 03:27 PM AEST| By Team Kalkine MediaHealius Limited (,ASX: HLS,) is witnessing a sharp decline in its stock price on 25 June 2024, plummeting as much as 0.33% to AU$1.49 apiece, marking its lowest level since 17 June 2024. The healthcare services provider faces significant challenges t...
ResMed Inc. (ASX: RMD) Faces Share Price Decline on Monday
June 24, 2024 03:28 PM AEST| By Team Kalkine MediaInvestors are witnessing a substantial downturn in ResMed Inc.'s (,ASX: RMD,) share price, which has plummeted by 13% to AU$27.790 in afternoon trading this Monday. The market reaction comes swiftly following the release of pivotal clinical trial res...
Telix Pharmaceuticals (ASX: TLX) Faces Share Price Dip as Nasdaq Listing Plans Axed
June 14, 2024 02:48 PM AEST| By Team Kalkine MediaInvestors in Telix Pharmaceuticals (,ASX: TLX,) are witnessing a downturn in the company's share price today as plans for a Nasdaq listing have been scrapped. After closing at AU$16.46 on Tuesday, shares were halted from trading pending details on th...
CSL (ASX: CSL) targets 13-17% profit growth in FY24
June 05, 2024 03:56 PM AEST| By Team KalkineHighlights,CSL is engaged in the research, development, manufacturing and distribution of biopharmaceutical products and services,In 1HFY24, CSL’s revenue jumped 12% YoY while EBITDA increased by 21% YoY,The Vanguard Group, Inc. has highest stake in...
Two ASX Healthcare Stocks Shine Amidst Market Challenges
June 04, 2024 01:46 PM AEST| By Team Kalkine MediaWhile the broader market grapples with subdued trading conditions, two ASX healthcare shares are defying the trend, posting solid gains on Tuesday. Despite the S&P/ASX 200 Index trading slightly lower, these standout performers are capturing investor...
Telix Pharmaceuticals (ASX: TLX) Soars on Positive Clinical Trial Results and FDA Progress
June 03, 2024 02:12 PM AEST| By Team Kalkine MediaInvestors in Telix Pharmaceuticals Ltd (,ASX: TLX,) are celebrating as the company's share price experiences a surge following positive developments in its clinical trials and regulatory progress. The ASX-listed biopharmaceutical company has witnesse...
Neuren Pharmaceuticals (ASX: NEU) Rollercoaster Week: From Clinical Trial Triumph to Stock Plunge, What Lies Ahead?
May 29, 2024 05:39 PM AEST| By Team Kalkine MediaShares of Neuren Pharmaceuticals (,ASX: NEU,) experienced a sharp decline, falling as much as 10% to AU$20.85, during afternoon trading hours of Wednesday. NEU, a company dedicated to developing therapies for neuro-developmental disorders, found itse...
Fisher & Paykel (ASX: FPH) Reaches New Heights with Strong Earnings Report
May 29, 2024 04:36 PM AEST| By Team Kalkine MediaIt's been a tough day for the S&P/ASX 200 Index, which has dropped 1.30%, pulling it below 7,700 points. However, one healthcare stock is defying the trend and making significant gains on Wednesday. Fisher & Paykel Healthcare Corporation Ltd (,ASX: F...
Pro Medicus (ASX: PME) Shares Surge on $45M Contract Wins
May 28, 2024 04:25 PM AEST| By Team Kalkine MediaShares of Pro Medicus (,ASX: PME,) surged as much as 1.26% to AU$114.67, during afternoon trading hours of Tuesday. The significant uptick in PME shares followed a positive announcement from the healthcare informatics company regarding its U.S. unit,...
Advertise your brand on Kalkine Media